GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Other Stockholders Equity

Scinopharm Taiwan (TPE:1789) Other Stockholders Equity : NT$843 Mil (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan Other Stockholders Equity?

Scinopharm Taiwan's Other Stockholders Equity for the quarter that ended in Dec. 2024 was NT$843 Mil.

Scinopharm Taiwan's quarterly Other Stockholders Equity increased from Jun. 2024 (NT$814 Mil) to Sep. 2024 (NT$855 Mil) but then declined from Sep. 2024 (NT$855 Mil) to Dec. 2024 (NT$843 Mil).

Scinopharm Taiwan's annual Other Stockholders Equity declined from Dec. 2022 (NT$683 Mil) to Dec. 2023 (NT$667 Mil) but then increased from Dec. 2023 (NT$667 Mil) to Dec. 2024 (NT$843 Mil).

Scinopharm Taiwan Other Stockholders Equity Historical Data

The historical data trend for Scinopharm Taiwan's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan Other Stockholders Equity Chart

Scinopharm Taiwan Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 669.05 650.99 682.53 667.47 843.50

Scinopharm Taiwan Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 667.47 687.95 813.67 854.51 843.50

Scinopharm Taiwan Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Scinopharm Taiwan Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Other Stockholders Equity
Comparable Companies
ROCO:4105 TPE:3705 TPE:1707 ROCO:4114 ROCO:6576 ROCO:6620 TPE:1720 TPE:4119 ROCO:6785 TPE:4746 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144
Website
https://www.scinopharm.com
Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines